Literature DB >> 20409610

The effects of APOE-ε4 on the BOLD response.

Aaron J Trachtenberg1, Nicola Filippini, Clare E Mackay.   

Abstract

In the last decade, functional magnetic resonance imaging (fMRI) has emerged as a tool to study changes in brain function associated with a genetic risk for Alzheimer's disease (AD), with a particular focus on the effects of the APOE-ε4 allele. This review compiles the existing literature concerning the effects of APOE genotype on the blood oxygen level dependent (BOLD) response, measured during task-based functional magnetic resonance imaging. While most studies report a significant difference in brain activity between carriers and noncarriers of the ε4 allele, there are inconsistencies in the direction and location of change. These inconsistencies were addressed by examining the effect of task, family history of Alzheimer's disease, and age on the relationship between APOE genotype and the BOLD response, but no clear pattern emerged. The review discusses the interpretation of BOLD differences between ε4 carriers and noncarriers, provides suggestions for future studies, and highlights important limitations of this type of research.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409610     DOI: 10.1016/j.neurobiolaging.2010.03.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  42 in total

1.  Longitudinal change in working memory as a function of APOE genotype in midlife and old age.

Authors:  Pamela M Greenwood; Thomas Espeseth; Ming-Kuan Lin; Ivar Reinvang; Raja Parasuraman
Journal:  Scand J Psychol       Date:  2014-06

2.  Imbalanced hippocampal functional networks associated with remitted geriatric depression and apolipoprotein E ε4 allele in nondemented elderly: a preliminary study.

Authors:  Hao Shu; Yonggui Yuan; Chunming Xie; Feng Bai; Jiayong You; Lingjiang Li; Shi-Jiang Li; Zhijun Zhang
Journal:  J Affect Disord       Date:  2014-04-02       Impact factor: 4.839

3.  Opposite Neural Trajectories of Apolipoprotein E ϵ4 and ϵ2 Alleles with Aging Associated with Different Risks of Alzheimer's Disease.

Authors:  Hao Shu; Yongmei Shi; Gang Chen; Zan Wang; Duan Liu; Chunxian Yue; B Douglas Ward; Wenjun Li; Zhan Xu; Guangyu Chen; Qihao Guo; Jun Xu; Shi-Jiang Li; Zhijun Zhang
Journal:  Cereb Cortex       Date:  2014-10-21       Impact factor: 5.357

4.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

5.  Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.

Authors:  William J Jagust; Susan M Landau
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

6.  Lifespan brain activity, β-amyloid, and Alzheimer's disease.

Authors:  William J Jagust; Elizabeth C Mormino
Journal:  Trends Cogn Sci       Date:  2011-10-07       Impact factor: 20.229

7.  Evidence for Reduced Autobiographical Memory Episodic Specificity in Cognitively Normal Middle-Aged and Older Individuals at Increased Risk for Alzheimer's Disease Dementia.

Authors:  Matthew D Grilli; Aubrey A Wank; John J Bercel; Lee Ryan
Journal:  J Int Neuropsychol Soc       Date:  2018-08-23       Impact factor: 2.892

Review 8.  Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Authors:  Marine Fouquet; Florent L Besson; Julie Gonneaud; Renaud La Joie; Gaël Chételat
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

9.  Distinct neural correlates of episodic memory among apolipoprotein E alleles in cognitively normal elderly.

Authors:  Hao Shu; Yongmei Shi; Gang Chen; Zan Wang; Duan Liu; Chunxian Yue; B Douglas Ward; Wenjun Li; Zhan Xu; Guangyu Chen; Qi-Hao Guo; Jun Xu; Shi-Jiang Li; Zhijun Zhang
Journal:  Brain Imaging Behav       Date:  2019-02       Impact factor: 3.978

Review 10.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.